Trade Summary

Yesterday, Coleman Mark, serving as Dir at Axsome Therapeutics, Inc. (AXSM), sold 643 shares at $249.00 per share, for a total transaction value of $160,107.00. Following this transaction, Coleman Mark now holds 30,389 shares of AXSM.

This sale represents a 2.07% decrease in Coleman Mark's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 (accepted Jun 10, 9:49 PM ET), 1 day after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.